Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
X-COR Therapeutics logo — company profile

X-COR Therapeutics

Founded 2017 United States Washington, United States 4 employees Seed Total: $2.80M Biotechnology, Health Care +1

General Information

Company Name X-COR Therapeutics
Founded Year 2017
Location United States Washington, United States +1
Employees 4
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when X-COR Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About X-COR Therapeutics

X-COR Therapeutics is a medical device company established in 2017 and based in the United States. The company is focused on creating the first commercially available CO2 removal device that utilizes ultra-low-blood flows. This pioneering technology aims to provide a cheaper, safer, and more accessible treatment for acute respiratory failure in the healthcare and biotechnology industries. In its latest funding round, X-COR Therapeutics secured $2.60M in a Seed Round with investment from The Graduate Syndicate, Alira Health Ventures, and PiSA Biopharm on 12 November 2020. This development signifies growing interest and support from notable investors, further validating the potential of X-COR Therapeutics' innovative approach in addressing critical medical needs. With its groundbreaking technology and strong financial backing, X-COR Therapeutics is well-positioned to make a significant impact in the healthcare sector.

Taxonomy: CO2 removal, acute respiratory failure, ultra-low-blood flows, treatment, intensive care, innovation, respiratory support, technological advancement

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round - X •••••• 3
Investor
•••• •••• 		12 Nov 2020
Seed Round - X •••••• 1
Investor
24 Mar 2020
Seed Round - X •••••• - 31 Jan 2019
Seed Round - X •••••• 1
Investor
12 Jun 2018

X-COR Therapeutics Alternatives & Competitors

X-COR Therapeutics vs
Foras Medikal
Foras Medikal Turkey

Solutions to Breath..

9 employees
Digital Health, Health Care
X-COR Therapeutics vs
Respiratory Motion
Respiratory Motion

Providing early warning of respiratory collapse across diverse patient populations and medical envir...

Series D
11-50 employees
Biotechnology, Health Care
X-COR Therapeutics vs
AirPhysio Pty Ltd
AirPhysio Pty Ltd Australia

Airway Physiotherapy For Naturally Better Breathing

17 employees
Health Care

FAQ About X-COR Therapeutics

X-COR Therapeutics is a medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.
X-COR Therapeutics was founded in 2017.
X-COR Therapeutics is headquartered in Washington, United States.
X-COR Therapeutics operates in the following industries: Biotechnology, Health Care, Medical Devices.
X-COR Therapeutics has approximately 4 employees.
X-COR Therapeutics has completed 4 funding rounds, raising a total of $2.80M. The latest funding stage is Seed.
Top alternatives and competitors to X-COR Therapeutics include Foras Medikal, Respiratory Motion, AirPhysio Pty Ltd, PEMDx, Ember Sleep. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
X-COR Therapeutics and Foras Medikal are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors X-COR Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy